TandemAI is focused on lowering the barrier to entry to the most advanced tools in drug discovery. We designed our fully integrated pre-clinical drug discovery platform to empower researchers to discover therapeutic candidates faster and more efficiently by democratizing access to the most innovative tools in drug discovery. We hope to dramatically improve the success rate of pre-clinical therapeutic candidates and, ultimately, help improve the lives of people waiting for new treatment options.
The Most Advanced Tools in Drug Discovery
TandemViz – The Next Generation Collaborative Tool for Drug DiscoveryTandemViz provides clients with web-based access to our suite of computational tools.
Physics-Based Molecular SimulationOur dynamic physics-based molecular simulations allow us to see how drugs interact and bind with protein atoms in motion.
Artificial IntelligenceWe apply artificial intelligence to ingest data, perform computations, and create models which lead to insights.
Supercomputing InfrastructureThe system architecture of our in-house supercomputing clusters is purpose-built to optimize our drug discovery workflows.
Recent Press Releases
-
TandemAI Raises $35 Million in Series A Financing to Expand Integrated Computational and Wet Lab Solutions to Accelerate Drug Discovery
-
TandemAI Announces Appointment of Alessandro Monge, Ph.D., as Chief Business Officer
-
TandemAI Announces Appointment of Steve Swann, Ph.D., as Chief Scientific Officer
A Culture of Collaboration
Our multi-functional teams of data scientists, physicists, biologists and chemists work in an environment of partnership and respect to accelerate and democratize the drug discovery process and advance human health.
Join Us
